Clinical Trials Directory

Trials / Completed

CompletedNCT02213731

Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)

Cryoballoon Ablation for Early Persistent Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Medtronic Cardiac Ablation Solutions · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical study is to assess the single procedure outcomes of using cryoballoon ablation without additional empirical lesions and/or complex fractionated electrogram (CFE) ablations for patients with early persistent atrial fibrillation (\<1 year from first diagnosis of persistent AF).

Conditions

Interventions

TypeNameDescription
OTHERHolter monitoringSubjects will wear holter monitors at baseline, 6 months and 12 months.

Timeline

Start date
2014-12-08
Primary completion
2017-06-22
Completion
2017-09-12
First posted
2014-08-11
Last updated
2025-02-13

Locations

14 sites across 3 countries: France, Germany, Greece

Source: ClinicalTrials.gov record NCT02213731. Inclusion in this directory is not an endorsement.